Chronic Kidney Disease

The National Kidney Foundation has awarded the Joel D. Kopple Award to Kathy Schiro Harvey, MS, RDN, CSR.

The FDA has declined to approve Dynavax’s supplemental biologics license application for the expanded use of its four-dose hepatitis B vaccine regimen in adult patients on hemodialysis, according to a manufacturer’s press release.

A “critical gap” between recommended and commonly used nephrology practices, including kidney replacement therapy-directed education, exists, according to a published study.

Tumor necrosis factor inhibitor use was independently associated with a greater risk for progressive kidney function decline but not risk for all-cause mortality among patients with new-onset inflammatory bowel disease, according to data.

Adverse drug reactions make up a major cause of hospitalization in patients with chronic kidney disease where lower eGFR is a risk factor, according to published data.

Targeted educational and training programs may help address barriers that could limit cystatin C use in clinical practice for enhanced chronic kidney disease detection, according to published data.

BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.

BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.

Co-chairs of a National Kidney Foundation-American Society of Nephrology task force on race in chronic kidney disease were named to the TIME list of the 100 most influential people in global health.

There may be a link between chronic kidney disease and the onset of migraines in Korean adults, according to data from a nationwide longitudinal follow-up study.